Download Citation
Article Source:
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
Björk P,
Björk A,
Vogl T,
Stenström M,
Liberg D,
et al.
(2009)
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides.
PLOS Biology 7(4): e1000097.
https://doi.org/10.1371/journal.pbio.1000097